On June 5, 2025, MEDIROM Healthcare Technologies Inc. announced that it has regained compliance with The Nasdaq Stock Market LLC's minimum bid price requirement. The company received notification from Nasdaq on June 4, 2025, confirming its compliance.
MEDIROM's American Depositary Shares (ADSs) maintained a closing bid price of $1.00 or more for 10 consecutive business days, from May 20, 2025, to June 3, 2025. This resolves the non-compliance notice received on February 27, 2025, which had set an August 26, 2025, deadline for regaining compliance.
The successful resolution of this listing matter removes a significant regulatory overhang for the company. This ensures MEDIROM's continued listing on Nasdaq, providing stability for its shareholders and supporting its ongoing strategic initiatives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.